Pregabalin 25 MG Oral Capsule — RxCUI 483442
RxNorm drug concept · Semantic clinical drug
RxCUI 483442
Semantic clinical drug · SCD
● Current RxNorm concept 334 FDA products
901 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI483442
Official namePregabalin 25 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped334
Package NDCs mapped901
Reported Medicaid activity (SDUD)2,053,094 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pregabalin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Pregabalin is used for a few different conditions depending on which product you're taking. Most commonly it's prescribed for nerve pain — either from diabetes (diabetic peripheral...
- Yes, dizziness and drowsiness are the most common side effects — and they're the main reason some people end up stopping the medication. They tend to show up shortly after you star...
- Will pregabalin make me feel dizzy or drowsy?
- Please don't stop abruptly. Stopping pregabalin suddenly can cause withdrawal symptoms like insomnia, nausea, headache, and anxiety. If you have a seizure disorder, stopping sudden...
🕸️ Concept Web — How Pregabalin 25 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pregabalin 25 MG Oral Capsule
RxCUI 483442 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Pregabalin
187832IN
-
Pregabalin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lyrica
593441BN
-
Lyrica
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pregabalin Oral Capsule
483437SCDF -
Pregabalin Oral Product
1156764SCDG -
Pregabalin Pill
1156765SCDG -
Pregabalin Oral Capsule [Lyrica]
607017SBDF -
Lyrica Oral Product
1182082SBDG -
Lyrica Pill
1182083SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Pregabalin Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pregabalin 25 MG
483441SCDC -
Pregabalin 25 MG Oral Capsule [Lyrica]
607026SBD -
Pregabalin 25 MG [Lyrica]
607025SBDC
-
Pregabalin 25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pregabalin 25 MG
SCDC · 483441 -
Pregabalin Oral Capsule
SCDF · 483437 -
Pregabalin Oral Product
SCDG · 1156764 -
Pregabalin Pill
SCDG · 1156765
Brand-Name Concepts
-
Pregabalin 25 MG Oral Capsule [Lyrica]
SBD · 607026 -
Pregabalin 25 MG [Lyrica]
SBDC · 607025 -
Pregabalin Oral Capsule [Lyrica]
SBDF · 607017 -
Lyrica Oral Product
SBDG · 1182082 -
Lyrica Pill
SBDG · 1182083 -
Lyrica
BN · 593441
📦 FDA Products & Package NDCs
334 products · 901 package NDCs
901 package NDCs map to RxCUI 483442 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69097-0956-05 | 90 CAPSULE in 1 BOTTLE (69097-956-05) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0956-12 | 500 CAPSULE in 1 BOTTLE (69097-956-12) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0957-05 | 90 CAPSULE in 1 BOTTLE (69097-957-05) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0957-12 | 500 CAPSULE in 1 BOTTLE (69097-957-12) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0958-05 | 90 CAPSULE in 1 BOTTLE (69097-958-05) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0958-12 | 500 CAPSULE in 1 BOTTLE (69097-958-12) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0959-05 | 90 CAPSULE in 1 BOTTLE (69097-959-05) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0961-05 | 90 CAPSULE in 1 BOTTLE (69097-961-05) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69097-0962-05 | 90 CAPSULE in 1 BOTTLE (69097-962-05) | Pregabalin | Cipla USA, Inc. | 2019-07-19 |
| 69238-1310-05 | 500 CAPSULE in 1 BOTTLE (69238-1310-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1310-09 | 90 CAPSULE in 1 BOTTLE (69238-1310-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1311-05 | 500 CAPSULE in 1 BOTTLE (69238-1311-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1311-09 | 90 CAPSULE in 1 BOTTLE (69238-1311-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1312-05 | 500 CAPSULE in 1 BOTTLE (69238-1312-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1312-09 | 90 CAPSULE in 1 BOTTLE (69238-1312-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1313-05 | 500 CAPSULE in 1 BOTTLE (69238-1313-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1313-09 | 90 CAPSULE in 1 BOTTLE (69238-1313-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1314-05 | 500 CAPSULE in 1 BOTTLE (69238-1314-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1314-09 | 90 CAPSULE in 1 BOTTLE (69238-1314-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1315-05 | 500 CAPSULE in 1 BOTTLE (69238-1315-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1315-09 | 90 CAPSULE in 1 BOTTLE (69238-1315-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1316-05 | 500 CAPSULE in 1 BOTTLE (69238-1316-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1316-09 | 90 CAPSULE in 1 BOTTLE (69238-1316-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1317-05 | 500 CAPSULE in 1 BOTTLE (69238-1317-5) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69238-1317-09 | 90 CAPSULE in 1 BOTTLE (69238-1317-9) | Pregabalin | Amneal Pharmaceuticals NY LLC | 2019-07-19 |
| 69367-0324-09 | 90 CAPSULE in 1 BOTTLE (69367-324-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0325-09 | 90 CAPSULE in 1 BOTTLE (69367-325-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0326-09 | 90 CAPSULE in 1 BOTTLE (69367-326-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0327-09 | 90 CAPSULE in 1 BOTTLE (69367-327-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0328-09 | 90 CAPSULE in 1 BOTTLE (69367-328-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0329-09 | 90 CAPSULE in 1 BOTTLE (69367-329-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0330-09 | 90 CAPSULE in 1 BOTTLE (69367-330-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0331-09 | 90 CAPSULE in 1 BOTTLE (69367-331-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2021-08-24 |
| 69367-0424-05 | 500 CAPSULE in 1 BOTTLE (69367-424-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0424-09 | 90 CAPSULE in 1 BOTTLE (69367-424-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0425-05 | 500 CAPSULE in 1 BOTTLE (69367-425-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0425-09 | 90 CAPSULE in 1 BOTTLE (69367-425-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0426-05 | 500 CAPSULE in 1 BOTTLE (69367-426-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0426-09 | 90 CAPSULE in 1 BOTTLE (69367-426-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0427-05 | 500 CAPSULE in 1 BOTTLE (69367-427-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0427-09 | 90 CAPSULE in 1 BOTTLE (69367-427-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0428-05 | 500 CAPSULE in 1 BOTTLE (69367-428-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0428-09 | 90 CAPSULE in 1 BOTTLE (69367-428-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0429-05 | 500 CAPSULE in 1 BOTTLE (69367-429-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0429-09 | 90 CAPSULE in 1 BOTTLE (69367-429-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0430-05 | 500 CAPSULE in 1 BOTTLE (69367-430-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0430-09 | 90 CAPSULE in 1 BOTTLE (69367-430-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0431-05 | 500 CAPSULE in 1 BOTTLE (69367-431-05) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 69367-0431-09 | 90 CAPSULE in 1 BOTTLE (69367-431-09) | Pregabalin | Westminster Pharmaceuticals, LLC | 2025-11-17 |
| 70518-3974-00 | 30 CAPSULE in 1 BLISTER PACK (70518-3974-0) | Pregabalin | REMEDYREPACK INC. | 2024-01-03 |
Observed labelers:
Proficient Rx LP (150) ·
Asclemed USA, Inc. (48) ·
Aphena Pharma Solutions - Tennessee, LLC (43) ·
Ascend Laboratories, LLC (40) ·
ScieGen Pharmaceuticals, Inc (40) ·
Camber Pharmaceuticals, Inc. (35)
· +38 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.